A 32-year-old man from rural India presents with a 3-month history of productive cough, fever, and night sweats. Chest X-ray shows cavitary lesions in the right upper lobe. Sputum smear microscopy is negative for acid-fast bacilli on two occasions. What is the most appropriate next investigation to confirm tuberculosis?

## Investigation of Choice for Smear-Negative TB **Key Point:** Sputum culture on Löwenstein-Jensen (LJ) medium or MGIT (mycobacterial growth indicator tube) is the gold standard confirmatory test for tuberculosis when sputum smear microscopy is negative but clinical suspicion remains high. ### Why Sputum Culture? Sputum culture is: - **Most specific** for *Mycobacterium tuberculosis* identification - **Gold standard** for TB diagnosis, especially in smear-negative cases - Allows **drug susceptibility testing (DST)** for MDR-TB detection - Can detect as few as **10–100 organisms per mL** (vs. 10,000–100,000 for smear microscopy) - Takes **2–8 weeks** on solid media (LJ) or **2–3 weeks** on liquid media (MGIT) ### Clinical Context This patient has: - **Cavitary disease** (highly suggestive of TB) - **Negative sputum smears** (smear-negative TB, ~10% of TB cases) - **Classic symptoms** (fever, night sweats, productive cough × 3 months) - **Risk factors** (rural India, endemic region) Smear-negative TB is still **infectious** and **must be confirmed** before starting treatment to avoid unnecessary drug exposure. ### Diagnostic Algorithm ```mermaid flowchart TD A[Clinical suspicion of TB + cavitary CXR]:::outcome --> B{Sputum smear positive?}:::decision B -->|Yes| C[Presumptive TB diagnosis]:::action B -->|No| D[Send sputum for culture]:::action D --> E[Culture on LJ/MGIT]:::action E --> F{Culture positive?}:::decision F -->|Yes| G[Confirm TB + DST]:::outcome F -->|No| H[Consider alternative diagnosis]:::outcome ``` **High-Yield:** Culture is **mandatory** in smear-negative cases before initiating anti-TB therapy to confirm diagnosis and detect drug resistance. [cite:Harrison 21e Ch 165] **Clinical Pearl:** In high-burden TB settings like India, empirical treatment of smear-negative TB with cavitary disease may be justified while awaiting culture results, but culture confirmation remains the diagnostic gold standard.